SCHEMBL12307572

SCHEMBL12307572

CNC(=O)Nc1cc2n(n1)CCN2c1ccc(C(=O)O)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ GRIK1 P39086 1/20 0.34
▸ ABCB1 P08183 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ HTT P42858 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ SSTR5 P35346 1/20 0.32
▸ HPGD P15428 2/20 0.32
▸ PPARG P37231 1/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ RCE1 Q9Y256 1/20 0.32
▸ GFER P55789 2/20 0.31
▸ PYGL P06737 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307568 0.92 TP53 (0.38) ALDH1A1ABCB1KDM4EMAPTHTT
SCHEMBL12307588 0.87 GCK (0.38) PYGL
SCHEMBL12307609 0.83 TTR (0.39) —
SCHEMBL12307539 0.83 MEN1 (0.42) ALDH1A1KDM4EMAPTHTTTP53
SCHEMBL12307522 0.82 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTTP53SMN1; SMN2
SCHEMBL12307484 0.81 KMT2A (0.40) ALDH1A1HTTNPSR1LMNAGAA
SCHEMBL12307398 0.80 GCK (0.40) ALDH1A1MAPTHTTSMN1; SMN2HSD17B10
SCHEMBL12307529 0.79 GAA (0.39) ALDH1A1MAPTGFERGAA
SCHEMBL12307511 0.79 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTTP53SMN1; SMN2
SCHEMBL12307527 0.78 ALDH1A1 (0.42) ALDH1A1MAPTTP53SMN1; SMN2PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 ALDH1A1 3559/4885GRIK1 2283/4885ABCB1 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback